ATE139259T1 - Selbstantigen der primären lebercirrhose - Google Patents
Selbstantigen der primären lebercirrhoseInfo
- Publication number
- ATE139259T1 ATE139259T1 AT88905561T AT88905561T ATE139259T1 AT E139259 T1 ATE139259 T1 AT E139259T1 AT 88905561 T AT88905561 T AT 88905561T AT 88905561 T AT88905561 T AT 88905561T AT E139259 T1 ATE139259 T1 AT E139259T1
- Authority
- AT
- Austria
- Prior art keywords
- adjectives
- liver
- self
- primary cirrhosis
- cirrhosis
- Prior art date
Links
- 206010016654 Fibrosis Diseases 0.000 title 1
- 230000007882 cirrhosis Effects 0.000 title 1
- 208000019425 cirrhosis of liver Diseases 0.000 title 1
- 210000004185 liver Anatomy 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 208000008439 Biliary Liver Cirrhosis Diseases 0.000 abstract 2
- 208000033222 Biliary cirrhosis primary Diseases 0.000 abstract 2
- 208000012654 Primary biliary cholangitis Diseases 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 230000002438 mitochondrial effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPH952386 | 1986-12-16 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE139259T1 true ATE139259T1 (de) | 1996-06-15 |
Family
ID=3771952
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT88905561T ATE139259T1 (de) | 1986-12-16 | 1987-12-16 | Selbstantigen der primären lebercirrhose |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US5196319A (de) |
| EP (1) | EP0293471B1 (de) |
| JP (3) | JP2815582B2 (de) |
| AT (1) | ATE139259T1 (de) |
| AU (1) | AU604087B2 (de) |
| CA (1) | CA1341231C (de) |
| DE (1) | DE3751834T2 (de) |
| NZ (1) | NZ222942A (de) |
| WO (1) | WO1988004689A1 (de) |
| ZA (1) | ZA879403B (de) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5395753A (en) * | 1993-02-19 | 1995-03-07 | Theratech, Inc. | Method for diagnosing rheumatoid arthritis |
| WO1995033476A1 (en) * | 1994-06-03 | 1995-12-14 | St. Luke's-Roosevelt Hospital Center | A PURIFIED 80 kDa PROTEIN IMPLICATED IN ABDOMINAL AORTIC ANEURYSMS, ANTIBODIES DIRECTED THERETO, AND USES THEREOF |
| US6048704A (en) | 1996-03-07 | 2000-04-11 | The Trustees Of Columbia University | Purified and recombinant antigenic protein associated with abdominal aortic aneurysm (AAA) disease, and diagnostic and therapeutic use thereof |
| AU717738B2 (en) * | 1996-06-24 | 2000-03-30 | Ross Coppel | Recombinant fusion protein comprising PDC-E2, BCOADC-E2, and OGDC-E2 and uses thereof |
| DE19805815C1 (de) | 1998-02-13 | 1999-11-11 | Ansgar W Lohse | Diagnostikum zum Erkennen der autoimmunen Hepatitis |
| GB0000992D0 (en) * | 2000-01-18 | 2000-03-08 | Astrazeneca Uk Ltd | Methods |
| AU2002254431A1 (en) * | 2001-03-27 | 2002-10-08 | M. Eric Gershwin | Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them |
| US9000040B2 (en) | 2004-09-28 | 2015-04-07 | Atrium Medical Corporation | Cross-linked fatty acid-based biomaterials |
| JP5710623B2 (ja) * | 2009-10-05 | 2015-04-30 | アンバージェン， インコーポレイテッド | 自己抗原を使用する原発性胆汁性肝硬変（ｐｂｃ）を診断するための方法 |
| CN104292322A (zh) * | 2012-03-23 | 2015-01-21 | 中国医学科学院北京协和医院 | 原发性胆汁性肝硬化特异性自身抗原及其应用 |
-
1987
- 1987-12-15 ZA ZA879403A patent/ZA879403B/xx unknown
- 1987-12-15 CA CA000554320A patent/CA1341231C/en not_active Expired - Fee Related
- 1987-12-16 JP JP62506357A patent/JP2815582B2/ja not_active Expired - Fee Related
- 1987-12-16 AT AT88905561T patent/ATE139259T1/de not_active IP Right Cessation
- 1987-12-16 DE DE3751834T patent/DE3751834T2/de not_active Expired - Lifetime
- 1987-12-16 NZ NZ222942A patent/NZ222942A/en unknown
- 1987-12-16 US US07/259,119 patent/US5196319A/en not_active Expired - Lifetime
- 1987-12-16 WO PCT/AU1987/000427 patent/WO1988004689A1/en not_active Ceased
- 1987-12-16 AU AU10868/88A patent/AU604087B2/en not_active Ceased
- 1987-12-16 EP EP88905561A patent/EP0293471B1/de not_active Expired - Lifetime
-
1994
- 1994-07-25 US US08/279,818 patent/US5891436A/en not_active Expired - Lifetime
-
1997
- 1997-01-06 JP JP9000184A patent/JP2875226B2/ja not_active Expired - Fee Related
-
1998
- 1998-05-12 JP JP10128968A patent/JPH1175864A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01502077A (ja) | 1989-07-27 |
| JPH09308490A (ja) | 1997-12-02 |
| EP0293471A4 (de) | 1990-05-14 |
| JPH1175864A (ja) | 1999-03-23 |
| US5196319A (en) | 1993-03-23 |
| AU604087B2 (en) | 1990-12-06 |
| AU1086888A (en) | 1988-07-15 |
| ZA879403B (en) | 1988-06-23 |
| DE3751834D1 (de) | 1996-07-18 |
| US5891436A (en) | 1999-04-06 |
| EP0293471A1 (de) | 1988-12-07 |
| DE3751834T2 (de) | 1996-11-07 |
| NZ222942A (en) | 1991-06-25 |
| WO1988004689A1 (en) | 1988-06-30 |
| CA1341231C (en) | 2001-05-15 |
| EP0293471B1 (de) | 1996-06-12 |
| JP2875226B2 (ja) | 1999-03-31 |
| JP2815582B2 (ja) | 1998-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI874819L (fi) | Human rekombinant endotelcell vaextfaktor. | |
| DE3783573D1 (de) | Komplex von pullulan und polyaethylenglykol. | |
| DK106687A (da) | Kirurgisk reparationsmateriale | |
| DE3585087D1 (de) | Retrovirale polypeptide in zusammenhang mit menschlicher transformation. | |
| DK162890D0 (da) | Polypeptid | |
| ATE139259T1 (de) | Selbstantigen der primären lebercirrhose | |
| DE3579148D1 (de) | Polypeptid und polypeptidzusammensetzung. | |
| DK551287D0 (da) | Polypeptid | |
| DE3781217D1 (de) | Herstellung von verwandten polypeptiden des bindungsfaktors. | |
| AT349607B (de) | Gekruemmter knochennagel und dazugehoeriges vorschlageisen zur fixierung von bruechen im proximalen oberschenkelbereich | |
| DE3778550D1 (de) | Fieber- und entzuendungshemmende peptide. | |
| FI883257A7 (fi) | Uudet peptidit. | |
| IT1048374B (it) | Perfezionamento nelle composizioni sterilizzanti e procedimento di sterilizzazione di oggetti con l uso di tali composizioni | |
| DK354487A (da) | Oncogen-relaterede peptider | |
| DE69132200D1 (de) | Immunaktive Peptidzusammensetzung gegen HTLV-Antikörper | |
| ZA761462B (en) | New l-3-(3,4-dihydroxyphenyl)-2-methylalanine peptides and the preparation thereof | |
| DE3886371D1 (de) | Herstellung des hblv-virus in der hsb-2 zell-linie. | |
| DE3586765D1 (de) | Immunogenische hav-peptide. | |
| ATE81134T1 (de) | Peptide. | |
| DK522582A (da) | Peptider, deres fremstilling og anvendelse | |
| SU561207A1 (ru) | Преоьразователь угла поворота вала в код | |
| DE2965929D1 (en) | Ovulation enhancing peptides and their pharmaceutical compositions | |
| IT8821191A0 (it) | Peptidi anoressizzanti e ipotensivi. | |
| ES553205A0 (es) | Perfeccionamientos en la construccion de autoclaves | |
| NO883697D0 (no) | Nytt pertussis toxin-avledet polypeptid og anvendelse derav. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |